CRP and type 2 diabetes mellitus: Fractalkine levels associated differentially with proinflammatory chemokines/cytokines as well as systemic CRP concentrations in diabetic and non-diabetic individuals which may have significant prognostic or therapeutic implications for T2D in humans.